Literature DB >> 8245463

Structure of the gene for the F allele of complement receptor type 1 and sequence of the coding region unique to the S allele.

D P Vik1, W W Wong.   

Abstract

The genes for human complement receptor type 1 (CR1) F and S alleles have been cloned and span a region of 133-160 kb on chromosome 1. The F allele was found to comprise 39 exons and the S allele contains an additional 8 exons. The leader sequence and 5'-untranslated region are contained in one exon. Each of the long homologous repeats (LHR), which contain seven short consensus repeats (SCR), is composed of 8 exons. Within a LHR, SCR 1, 5, and 7 are each encoded by a single exon, SCR 2 and 6 are each encoded by 2 exons, and a single exon codes for SCR 3 and 4. The transmembrane region is encoded by 2 exons and the cytoplasmic domain and the 3'-untranslated regions are coded for by separate exons. The sequences of the eight S allele-specific exons were very similar to those from LHR-A and -B, as was predicted by comparison of the genomic restriction maps. It had previously been suggested that the alleles of CR1 have arisen by a mechanism of unequal crossover. A comparison of intron sequences from LHR-A, -B, -C, and -S revealed data that support this hypothesis. The homologies of intron sequences from LHR-A, -B, and -C indicated that the crossover event between LHR-A and -C that gave rise to LHR-B probably occurred within the fourth exon of these LHR. Likewise, the crossover event between LHR-A and -B that produced LHR-S probably occurred within a 383 bp region around the sixth exon. Analysis of RNA from peripheral blood cells by the S1 nuclease assay indicated that the transcription start site is 111 bp upstream of the translation initiation codon ATG. The 5' rapid amplification of cDNA ends confirmed this position as a transcription start site and revealed another possible start site 29 bp further upstream.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245463

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Structure of the human aggrecan gene: exon-intron organization and association with the protein domains.

Authors:  W B Valhmu; G D Palmer; P A Rivers; S Ebara; J F Cheng; S Fischer; A Ratcliffe
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

2.  Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3' untranslated regions of the CR1 gene.

Authors:  I A Cockburn; J A Rowe
Journal:  Int J Immunogenet       Date:  2006-02       Impact factor: 1.466

Review 3.  Human gene copy number variation and infectious disease.

Authors:  Edward J Hollox; Boon-Peng Hoh
Journal:  Hum Genet       Date:  2014-06-05       Impact factor: 4.132

Review 4.  Transcriptional control of complement receptor gene expression.

Authors:  Brian K Martin
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

5.  No Evidence that Knops Blood Group Polymorphisms Affect Complement Receptor 1 Clustering on Erythrocytes.

Authors:  O V Swann; E M Harrison; D H Opi; E Nyatichi; A Macharia; S Uyoga; T N Williams; J A Rowe
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

6.  Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer's disease.

Authors:  Ezgi Kucukkilic; Keeley Brookes; Imelda Barber; Tamar Guetta-Baranes; Kevin Morgan; Edward J Hollox
Journal:  Hum Genet       Date:  2018-04-19       Impact factor: 4.132

7.  Complement receptor 1 variants confer protection from severe malaria in Odisha, India.

Authors:  Aditya K Panda; Madhumita Panda; Rina Tripathy; Sarit S Pattanaik; Balachandran Ravindran; Bidyut K Das
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

8.  Circulating Immune Complex Levels are Associated with Disease Severity and Seasonality in Children with Malaria from Mali.

Authors:  Bolaji N Thomas; Dapa A Diallo; Ghislain T Noumsi; Joann M Moulds
Journal:  Biomark Insights       Date:  2012-07-03

9.  Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.

Authors:  Y U Kim; T Kinoshita; H Molina; D Hourcade; T Seya; L M Wagner; V M Holers
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

10.  Increased survival in B-cell-deficient mice during experimental cerebral malaria suggests a role for circulating immune complexes.

Authors:  Rosane B de Oliveira; Jennifer P Wang; Sanjay Ram; Ricardo T Gazzinelli; Robert W Finberg; Douglas T Golenbock
Journal:  MBio       Date:  2014-03-18       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.